Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuyanxiao Capsules is a Traditional Chinese Medicine (TCM) product developed and marketed by Guizhou Yibai Pharmaceutical. It is a Chinese Patent Medicine (Zhongchengyao) primarily indicated for the treatment of gynecological inflammatory conditions, including chronic pelvic inflammatory disease, endometritis, and adnexitis. The formulation is a combination of several herbal ingredients, typically including *Sargentodoxa cuneata* (Daxueteng), *Patrinia villosa* (Baijiangcao), *Cyperus rotundus* (Xiangfu), and *Viola yedoensis* (Zihua Diding). These components are traditionally used in TCM to clear heat, detoxify, and promote blood circulation to resolve stasis. The drug exerts multi-target anti-inflammatory and analgesic effects, helping to alleviate symptoms such as abdominal pain and abnormal vaginal discharge associated with pelvic infections. It is administered orally in capsule form and is approved for marketing in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuyanxiao Capsules.